Table 2 Unadjusted and adjusted linear regression models to predict zone diameters of inhibition by year for ceftriaxone, cefixime, and azithromycin. The coefficient (β) is the slope of the regression line in mm
From: Trends in antimicrobial resistance in Neisseria gonorrhoeae in Hanoi, Vietnam, 2017–2019
Antibiotic | Variable | Unadjusted | Adjusted | ||
|---|---|---|---|---|---|
β (95% CI) | p value | β (95% CI) | p value | ||
Cefixime | Year | - 0.50 (−1.04, 0.04) | 0.069 | −0.49 (−1.04, 0.05) | 0.074 |
Age | 0.02 (−0.04, 0.08) | 0.467 | 0.02 (−0.03, 0.08) | 0.446 | |
Sex | 0.34 (−1.02, 1.70) | 0.624 | 0.25 (− 1.11, 1.62) | 0.717 | |
Ceftriaxone | Year | −0.83 (− 1.30, − 0.36) | 0.001 | − 0.83 (−91.30, − 0.35) | 0.001 |
Age | 0.003 (− 0.05, 0.04) | 0.90 | −0.002 (− 0.05, 0.05) | 0.93 | |
Sex | 0.22 (−0.97, 1.41) | 0.72 | 0.04 (−1.14, 1.22) | 0.95 | |
Azithromycin | Year | −0.83 (−1.33, − 0.33) | 0.001 | −0.81 (− 1.31, − 0.31) | 0.002 |
Age | 0.12 (− 0.04, 0.06) | 0.66 | 0.14 (− 0.04, 0.06) | 0.59 | |
Sex | 0.81 (−0.44, 2.06) | 0.20 | 0.65 (−0.59, 1.90) | 0.30 | |